A

AstraZeneca

Global pharmaceutical company developing prescription medicines

Early Asset Manager

Business AnalysisConfirmed live in the last 24 hours
Full-timeHamburg, GermanyNo salary listed

About the Job

Requirements

  • A completed university degree, such as in medicine, pharmacy, natural sciences, health economics, business administration, or a comparable field.
  • Several years of relevant professional experience in the pharmaceutical industry, ideally at the intersection of commercial or strategy, market access, pricing, policy, medical, or evidence.
  • Ability to structure complex topics quickly and present them clearly, concisely, and in an action-oriented manner for decision-makers.
  • Demonstrated stakeholder-management strength in a matrix organization, including facilitation, alignment, and driving decisions.
  • Ability to derive hypotheses, scenarios, and initial business logic, such as patient funnels, forecasts, and price or reimbursement drivers, and identify key value drivers early.
  • Good knowledge of the German healthcare system, especially reimbursement logic and evidence requirements, and ability to derive implications for development and evidence strategy.
  • High self-motivation, execution capability, and willingness to proactively advance topics amid uncertainty and define pragmatic next steps.
  • Very good spoken and written German and English, and confidence interacting with senior stakeholders.
  • Willingness to undertake occasional business travel.

Responsibilities

  • Organize and facilitate an early integrated asset assessment before Phase 3 investment decisions, incorporating a cross-functional German perspective on clinical trial plans, target populations, positioning, competition, healthcare and guideline landscapes, reimbursement, pricing scenarios, and initial patient funnel and forecast.
  • Prepare decision materials and align recommendations with management to provide robust local input to regional and global stakeholders.
  • Identify critical success factors from gaps and risks and derive concrete actions, including additional evidence generation, market shaping, policy, reimbursement or guideline strategy, and transformation needs such as novel market models.
  • Develop and manage early asset plans after a positive Phase 3 decision, deepen asset work until handover to the brand team, typically about two years before launch, and prioritize assets with high business impact or corporate priority.
  • Bring together relevant functions, including Medical, Market Access and Pricing, Policy, Evidence Generation, Business Analytics, Regulatory, and Commercial, and ensure dependencies, timing, and accountabilities are transparent.
  • Initiate and, where appropriate, lead focused task forces and drive implementation and follow-up.
  • As needed for an asset, support early external consultations on evidence requirements, including health technology assessment and benefit-assessment questions, application and preparation, internal alignment, and follow-up.

About the Company

AstraZeneca

Global pharmaceutical company developing prescription medicines

AstraZeneca develops and markets prescription medicines and vaccines worldwide, with a focus on oncology, cardiovascular/metabolic, respiratory, and infectious diseases. Its products work by targeting specific biological pathways or cells, using small-molecule therapies, biologics, and vaccines to treat diseases or prevent infections. It differentiates itself through its dual heritage from Sweden and the UK, a broad pipeline, and strong R&D and collaborations that move from discovery to patient access. Its goal is to improve people’s health by discovering, developing, and delivering medicines and vaccines to patients worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913

Recently Posted Jobs

Explore more opportunities at AstraZeneca

See more jobs